Feature | May 05, 2015

World’s First Physician-Owned Proton Therapy Center Treats First Patient

Jacksonville, Florida facility employs Mevion single-room proton therapy system

Ackerman Cancer Center, Mevion S250, Jacksonville, physician-owned

May 5, 2015 — Ackerman Cancer Center in Jacksonville, Florida, treated its first four proton therapy patients at the end of April, becoming the first private, physician-owned practice to offer this advanced form of radiation therapy. Within the first week of operation with the new system — a Mevion S250 — eight patients began proton therapy, with cancers affecting the parotid (salivary gland), prostate, tongue and base of the skull.

Before the introduction of the Mevion S250, proton therapy systems were the size of a football field and cost hundreds of millions of dollars to build and operate, thus limiting patient access. Mevion’s proton therapy system is installed into a single room with a footprint similar to a conventional radiation therapy unit, allowing it to be integrated with any size cancer facility. In addition, the Mevion system features greatly decreased capital and operating costs and is more environmentally friendly – using as much as 90 percent less energy than traditional systems.

Proton therapy targets cancer cells more precisely than traditional photon radiation treatment and results in less damage to surrounding healthy tissue and organs. Because of these attributes, it is ideal for treating pediatric patients and adult patients with cancers in sensitive locations, such as near the brain, spine, heart and lungs.

“We are a full-service cancer center, offering a complement of treatment options – allowing us to choose the modality that is most appropriate for each patient,” said Scot Ackerman, M.D., radiation oncologist and medical director of Ackerman Cancer Center. “Proton therapy is an important radiation oncology treatment and one that our patients deserve to be able to access as we help them fight their cancers.”

Ackerman Cancer Center’s system is the second clinically operational Mevion S250, with the other located at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri. One-year clinical results indicate it took less than 11 months to complete treatment of its first 100 patients – the fastest per room ramp-up of any proton therapy system. Additionally, the system demonstrated efficient treatment time identical to X-ray therapy, the ability to treat a diverse and complex array of cancers and operational uptime reaching 97 percent.

For more information: www.mevion.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more